technetium has been researched along with gemcitabine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Angelov, CA; Cavell, R; El-Mabhouh, AA; Mercer, JR | 1 |
| Abele, JT; El-Mabhouh, AA; McEwan, AJ; Mercer, JR; Nation, PN; Postema, E; Riauka, T | 1 |
| Ichedef, C; Karatay, KB; Teksöz, S; Yilmaz, S | 1 |
3 other study(ies) available for technetium and gemcitabine
| Article | Year |
|---|---|
A 99mTc-labeled gemcitabine bisphosphonate drug conjugate as a probe to assess the potential for targeted chemotherapy of metastatic bone cancer.
Topics: Animals; Bone Neoplasms; Deoxycytidine; Diphosphonates; Female; Gemcitabine; Kidney; Liver; Mice; Mice, Inbred BALB C; Technetium; Tissue Distribution | 2006 |
A conjugate of gemcitabine with bisphosphonate (Gem/BP) shows potential as a targeted bone-specific therapeutic agent in an animal model of human breast cancer bone metastases.
Topics: Animals; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Calcium; Creatinine; Deoxycytidine; Diphosphonates; Disease Models, Animal; Drug Delivery Systems; Female; Gemcitabine; Humans; Injections, Intralesional; Mice; Mice, Inbred BALB C; Mice, Nude; Positron-Emission Tomography; Technetium; Tumor Cells, Cultured | 2011 |
Polymer Coated Iron Nanoparticles: Radiolabeling & In vitro Studies.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Delivery Systems; Gemcitabine; Humans; In Vitro Techniques; Magnetic Iron Oxide Nanoparticles; Polymers; Radiopharmaceuticals; Technetium | 2021 |